
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Meropenem extended infusion stability has long been a challenge for critical care and infectious disease specialists. While traditional package inserts limit room-temperature stability to just one hour, clinical practice often requires longer windows for optimized drug delivery. Recent evidence now confirms that meropenem remains stable for significantly longer periods when diluted in normal saline.
Researchers recently evaluated the chemical stability of meropenem (1 g) diluted in 100 mL of 0.9% sodium chloride (NS). They stored the solutions at controlled room temperatures between 23-25 °C and used high-performance liquid chromatography (HPLC) to measure degradation. The study found that meropenem maintained over 90% of its initial concentration for up to 12 hours. However, by the 24-hour mark, the concentration fell to approximately 86.65%, which is below the acceptable threshold.
This extended stability window has profound implications for antimicrobial stewardship. Meropenem is a time-dependent antibiotic, meaning its efficacy depends on the duration that the free drug concentration remains above the Minimum Inhibitory Concentration (MIC). Consequently, prolonged infusions are the gold standard for treating severe infections. Furthermore, a 12-hour stability period simplifies nursing workflows and pharmacy compounding, as it removes the need for immediate, high-pressure administration. Clinicians should note that these findings specifically apply to polyvinyl chloride bags and normal saline diluents. Therefore, switching to dextrose or higher temperatures may still compromise drug integrity.
Meropenem is highly sensitive to heat. While it remains stable for 12 hours at 23-25 °C, stability drops significantly at higher temperatures (e.g., above 30 °C), which is a common concern in warmer clinical environments without climate control.
Studies consistently show that meropenem degrades much faster in dextrose-based solutions. For extended or continuous infusions, 0.9% sodium chloride is the mandatory diluent to ensure the drug remains therapeutically active.
Yes, higher concentrations of meropenem tend to degrade more rapidly. The 12-hour stability finding is specific to a concentration of approximately 10-13 mg/mL in a 100 mL bag.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Howington GT et al. Extended stability of meropenem in 0.9% sodium chloride injection stored at 23-25 °C. Am J Health Syst Pharm. 2026 Apr 04. doi: undefined. PMID: 41935840.
2. Mollá-Cantavella S et al. Intravenous meropenem stability in physiological saline at room temperature. Eur J Hosp Pharm. 2014;21:A128.
3. Yu Z et al. Clinical outcomes of prolonged infusion versus intermittent bolus of meropenem in severe infection: A meta-analysis. PLoS One. 2018;13(7):e0201667.
"
A new study demonstrates that meropenem in 0.9% sodium chloride is stable for up to 12 hours at room temperature, enabling more effective extended infusions...
last month

A study compares machine learning fusion strategies to improve non-invasive renal fibrosis assessment in CKD patients, highlighting decision-level superiori...
Today

Research shows that FABP5 suppresses the PPARγ/CPT1A pathway, boosting energy and lowering ROS to resist chemotherapy in cervical cancer cells....
Today

A pioneering study in Beagle dogs evaluates 3D-printed pimobendan tablets, demonstrating the potential for personalized drug delivery in veterinary medicine...
Today

An in-depth analysis of gene expression in embryonic chick skulls, focusing on matrix components like VCAN and IBSP in bone and cartilage development....
Today

A large-scale study reveals a 25% higher risk of CKD in night shift workers, largely driven by obesity and disrupted fatty acid metabolism....
Today